Terry Rosen, Ph.D., is a distinguished leader in the biotechnology industry, currently serving as the Chief Executive Officer and Director at Arcus Biosciences Inc. Dr. Rosen's journey in the field of life sciences began with his academic pursuits, culminating in a Ph.D. in Organic Chemistry from the University of California, Berkeley. His early career was marked by significant research contributions in medicinal chemistry, which laid the foundation for his later achievements in drug development. Before joining Arcus Biosciences, Dr. Rosen held several key leadership positions at major pharmaceutical companies, including Roche and Gilead Sciences. At Gilead, he played a pivotal role in the development of groundbreaking antiviral therapies that have had a profound impact on global health. His expertise in drug discovery and development, combined with his strategic vision, made him an ideal candidate to lead Arcus Biosciences, a company focused on creating innovative cancer immunotherapies. Under his leadership, Arcus has advanced multiple clinical programs and forged strategic partnerships with industry giants, positioning the company at the forefront of cancer research. As CEO and Director, Dr. Rosen is responsible for steering Arcus Biosciences towards its mission of transforming the treatment landscape for cancer patients. His strategic oversight has been instrumental in the company's growth and success, as evidenced by the progress of its pipeline and the expansion of its research capabilities. Dr. Rosen's dedication to scientific excellence and patient-centric innovation continues to drive Arcus Biosciences forward, making him a respected figure in the biotechnology community.